Meet Dr. Charles B. Hensley

Dr. Charles B. Hensley is a distinguished entrepreneur, scientist, and artist whose career has been characterized by groundbreaking innovations, creative pursuits, and resilience in the face of adversity. His life took a dramatic turn in 2020 when he suffered a life-threatening aneurysm caused by blood clots—an event that profoundly impacted his outlook and trajectory. Despite this challenge, Hensley's unwavering determination and resilience propelled him into new realms of achievement, storytelling, and artistic expression.

Before 2020
Hensley's academic journey and professional accomplishments are as diverse as they are impressive. He earned a Bachelor of Science degree in Zoology from the University of Oklahoma, where he also showcased his athletic talent as a college football player. His deep interest in marine biology led him to California State University, Long Beach, where he conducted research on shark behavior under the mentorship of renowned biologist Don Nelson.

He further advanced his expertise by obtaining a Ph.D. in Physiology and Biophysics from the University of Southern California (USC), specializing in neuroscience and physiology. His scientific pursuits led to entrepreneurial ventures, most notably the co-founding of Zicam LLC (formerly Gel Tech), where he pioneered a homeopathic cold remedy that revolutionized over-the-counter treatments.

Between 2003 and 2005, Hensley expanded his global footprint by working in Taiwan and Hong Kong, engaging in research and business activities during the SARS-CoV-1 outbreak. SARS-CoV-1 is the virus responsible for the severe acute respiratory syndrome (SARS) epidemic that affected the world from 2002 to 2004. The virus was later distinguished as SARS-CoV-1 to differentiate it from the related SARS-CoV-2, which causes COVID-19.

His scientific expertise also contributed to the development of therapies for neurological conditions such as migraines through his company Migranade, Inc. Beyond science, Hensley demonstrated leadership in the arts—serving as Chairman and CEO of REPRISE 2.0, a performing arts organization dedicated to fostering creativity, cultural expression, and artistic innovation.

His artistic talents, combined with his scientific curiosity, have been recognized on platforms like Saatchi Art, celebrating his unique ability to blend science and creativity. Throughout his multifaceted career, Hensley has relentlessly pursued innovation across disciplines, embodying a true trailblazer.

After 2020
The aneurysm and subsequent recovery marked a pivotal turning point in Hensley's life, inspiring a new chapter of storytelling and creative exploration. Drawing from his personal experiences, he embarked on the project Cold Wars: The Zicam Story—a biographical book and an upcoming film that chronicles his high-stakes journey of developing Zicam, a revolutionary cold remedy.

The narrative details his battles against the pharmaceutical establishment, the intense challenges of innovation, and his transformation from a respected researcher into a rebellious trailblazer challenging industry norms. Described as a "cinematic saga" and "high-octane" biography, the story captures the drama, grit, and ingenuity behind his ventures.

Hensley actively promotes the project as a film, emphasizing its cinematic quality and fast-paced storytelling reminiscent of Hollywood thrillers. His expansion into film and television production has led him to establish a holding company dedicated to managing cross-media projects, further broadening his influence in entertainment and storytelling.

Most recently, the story continues with *FLU WARS: VIRA 38*, another compelling narrative emerging from his journey, further exemplifying his commitment to innovative storytelling and creative expression.

Throughout his journey, Hensley's life embodies resilience, innovation, and artistic daring—resonating deeply with audiences who admire trailblazers defying the odds and pushing boundaries in science, arts, and entrepreneurship.